Anesth Analg 1999;89:717
© 1999 International Anesthesia Research Society
REGIONAL ANESTHESIA AND PAIN MANAGEMENT
Acute Phase Histopathological Study of Spinally Administered Midazolam in Cats
Tomoki Nishiyama, MD, PhD*,
Takashi Matsukawa, MD, PhD , and
Kazuo Hanaoka, MD, PhD*
*Department of Anesthesiology, The University of Tokyo, Faculty of Medicine, Tokyo, Japan; and
Department of Anesthesia, Yamanashi Medical University, Yamanashi, Japan
Address correspondence and reprint requests to Tomoki Nishiyama, MD, PhD, 3-2-6-603, Kawaguchi, Kawaguchi-shi, Saitama, 332-0015, Japan.
Midazolam may be a useful analgesic when administered intrathecally. However, neurotoxicity must be excluded. The purpose of this study was to investigate whether spinally administered midazolam induces acute-phase histopathological or inflammatory reactions of the spinal cord. A lumbar laminectomy was performed on 40 cats, and their spinal cords were exposed. Midazolam 10 mg (2 mL, n = 20 cats) or saline 2 mL (20 cats) was administered directly to the spinal cord. At 1, 2, 4, or 6 h after the administration, cats were killed, and the lumbar spinal cord was removed and fixed in 10% formalin. Histology was examined using light microscopy with hematoxylin and eosin staining. Both groups showed slight to moderate changes in the spinal cord, but no severe damage was observed. Inflammatory reactions were seen in only one cat in the saline group with slight neutrophil infiltration. These changes were not different between the midazolam group and the saline group. In conclusion, up to 6 h after direct exposure to midazolam, no acute histological damage or inflammatory reaction of the spinal cord was seen in cats.
Implications: Spinally administered midazolam, even in large doses, does not cause acute neurotoxicity or inflammation of the spinal cord.
This article has been cited by other articles:

|
 |

|
 |
 
A. P. Tucker, C. Lai, R. Nadeson, and C. S. Goodchild
Intrathecal Midazolam I: A Cohort Study Investigating Safety
Anesth. Analg.,
June 1, 2004;
98(6):
1512 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Tucker, J. Mezzatesta, R. Nadeson, and C. S. Goodchild
Intrathecal Midazolam II: Combination with Intrathecal Fentanyl for Labor Pain
Anesth. Analg.,
June 1, 2004;
98(6):
1521 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Yaksh and J. W. Allen
The Use of Intrathecal Midazolam in Humans: A Case Study of Process
Anesth. Analg.,
June 1, 2004;
98(6):
1536 - 1545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nishiyama and K. Hanaoka
Midazolam Can Potentiate the Analgesic Effects of Intrathecal Bupivacaine on Thermal- or Inflammatory-Induced Pain
Anesth. Analg.,
May 1, 2003;
96(5):
1386 - 1391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Walker, L. C. Goudas, M. J. Cousins, and D. B. Carr
Combination Spinal Analgesic Chemotherapy: A Systematic Review
Anesth. Analg.,
September 1, 2002;
95(3):
674 - 715.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nishiyama and K. Hanaoka
The Synergistic Interaction Between Midazolam and Clonidine in Spinally-Mediated Analgesia in Two Different Pain Models of Rats
Anesth. Analg.,
October 1, 2001;
93(4):
1025 - 1031.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|